Global Vagus Nerve Stimulator Market Size, Trends & Growth Opportunity, By Product Type (Implantable VNS Devices, and External VNS Devices), By Biomaterial (Ceramics, Metallic, and Polymerics), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Report ID : IR100392 | Industries : Healthcare | Published On :May 2024 | Page Count : 248
Global Vagus Nerve Stimulator Market Size, Trends & Growth Opportunity, By Product Type (Implantable VNS Devices, and External VNS Devices), By Biomaterial (Ceramics, Metallic, and Polymerics), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global Vagus Nerve Stimulator Market
Global Vagus Nerve Stimulator Market was valued at USD 555.2 million in 2021 and is expected to reach USD 1195.9 million by 2027, at a CAGR 12.15% from 2022-2027.
Vagus nerve Stimulator (VNS) is a medical treatment which involves delivering electrical impulses to the vagus nerve. It uses an implanted device to send an electrical pulse to one’s vagus nerve, which then travels to one’s brain. Vagus nerve stimulators are also called vagus nerve stimulation. Surgeons implant a device near the collarbone and run a wire to the vagus nerve. When the device fires it stimulates that nerve to send signals to the brain. This increases activity in areas that control mood.
Market Drivers
Rising prevalence of neurological disorders is the key driving factor which is expected to drive the global vagus nerve stimulator market growth. Also, increase in investments in pharmaceutical and biotechnology industries and research and development activities will have a positive impact on market growth.
Moreover, growing technological advancements and increase in prevalence of neurological disorders such as epilepsy, depression, anxiety, and others is expected to boost growth of the global vagus nerve stimulators market over the forecast period 2027.
Market Restraints
The lack of skilled professionals is the major challenging factor which is expected to obstruct the global vagus nerve stimulator market growth. High costs associated with neurostimulator devices are also expected to hinder the market growth.
Market Segmentation
The Global Vagus Nerve Stimulator Market is segmented into product, biomaterial, application, end user, and region.
Based on biomaterial, the Vagus Nerve Stimulator market is segmented into polymeric, metallic, and ceramic biomaterials. The polymeric segment is expected to advance at the highest growth rate of 2022 to 2037, owing to its flexibility benefits.
Regional Analysis
Global Vagus Nerve Stimulator Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region dominates the vagus nerve stimulation market, owing to the growing government funding and initiatives for raising awareness about epilepsy and difficult-to-treat depression in the region. Also, rapid technological advancements, key manufacturers in the region, are among the key factors expected to create significant growth opportunities in the North American market.
Key Players
Various key players are discussed into the Global Vagus Nerve Stimulator Market Report including: Medtronic Plc, Nevro Corporation, EnteroMedics Inc, Bioness Inc, BioControl Medical, Aleva Neurotherapeutics SA, Boston Scientific Corporation, LivaNova Plc, ElectroCore LLC, and NeuroPace Inc.
For instance, in March 2020, LivaNova had received the CE Mark approval for their VNS Therapy System - Symmetry - for difficult-to-treat depression. Such key players operating in the industry are increasingly focusing on technological advancements, product launches, and other growth strategies, such as mergers & acquisitions, to strengthen their foothold in the market.
Market Taxonomy
By Product Type
• Implantable VNS Devices
• External VNS Devices
By Biomaterial
• Ceramics
• Metallic
• Polymerics
By Application
• Depression
• Epilepsy
• Migraine
By End User
• Hospitals
• Ambulatory Surgical Centres
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Vagus Nerve Stimulator Market TOC:
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Vagus Nerve Stimulator Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Vagus Nerve Stimulator Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Vagus Nerve Stimulator Market Share Analysis, By Product Type
5.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Product Type
5.3.1 Implantable VNS Devices
5.3.2 External VNS Devices
6 Global Vagus Nerve Stimulator Market, By Biomaterial
6.1 Y-o-Y Growth Comparison, By Biomaterial
6.2 Global Vagus Nerve Stimulator Market Share Analysis, By Biomaterial
6.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
6.3.1 Ceramics
6.3.2 Reusable
6.3.3 Polymerics
7 Global Vagus Nerve Stimulator Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Vagus Nerve Stimulator Market Share Analysis, By Application
7.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Application
7.3.1 Depression
7.3.2 Epilepsy
7.3.3 Margarine
8 Global Vagus Nerve Stimulator Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Vagus Nerve Stimulator Market Share Analysis, By End User
8.3 Global Vagus Nerve Stimulator Market Size and Forecast, By End User
8.3.1 Hospitals
8.3.2 Ambulatory Surgical Center
8.3.3 Others
9 Global Vagus Nerve Stimulator Market, By Region
9.1 Global Vagus Nerve Stimulator Market Share Analysis, By Region
9.2 Global Vagus Nerve Stimulator Market Share Analysis, By Region
9.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Region
10 North America Vagus Nerve Stimulator Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 North America Vagus Nerve Stimulator Market Share Analysis, By Product Type
10.3 North America Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
10.4 North America Vagus Nerve Stimulator Market Size and Forecast, By Application
10.5 North America Vagus Nerve Stimulator Market Size and Forecast, By End User
10.6 North America Vagus Nerve Stimulator Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11 Europe Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Europe Vagus Nerve Stimulator Market Share Analysis, By Product Type
11.3 Europe Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
11.4 Europe Vagus Nerve Stimulator Market Size and Forecast, By Application
11.5 Europe Vagus Nerve Stimulator Market Size and Forecast, By End User
11.6 Europe Vagus Nerve Stimulator Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe
12 Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Asia Pacific Vagus Nerve Stimulator Market Share Analysis, By Product Type
12.3 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
12.4 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Application
12.5 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By End User
12.6 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4 Rest of Asia Pacific
13 Latin America Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Latin America Vagus Nerve Stimulator Market Share Analysis, By Product Type
13.3 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
13.4 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Application
13.5 Latin America Vagus Nerve Stimulator Market Size and Forecast, By End User
13.6 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Country
13.6.1 Brazil
13.6.2 Rest of Latin America
14 Middle East Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
14.1 Introduction
14.2 Middle East Vagus Nerve Stimulator Market Share Analysis, By Product Type
14.3 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
14.4 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Application
14.5 Middle East Vagus Nerve Stimulator Market Size and Forecast, By End User
14.6 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Country
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3 Egypt
14.6.4 Kuwait
14.6.5 South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Medtronic Plc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Nevro Corporation
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 EnteroMedics Inc.
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Bioness Inc.
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 BioControl Medical
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Aleva Neurotherapeutics SA
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Boston Scientific Corporation
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 LivaNova Plc
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 ElectroCore LLC
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 NeuroPace Inc.
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies